Comprehensive Multi-omics Characterization and Implications of Non-Pharmaceutical Dental Hygiene Product in a Randomized Controlled Large Population Study.

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
Delta Dental of Minnesota Foundation
Study ID
NCT07451782
Status
Completed

Conditions

  • Basic Science
  • Biomarker Discovery
  • Intervention Studies

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Oral Lozenges (Tradename pHossident) — DIETARY_SUPPLEMENT
    dissolvable mint flavored pHossident lozenges containing ingredients that are all FDA-approved with the GRAS (Generally Recognized As Safe) designation, and have years of safety demonstrated in animals, children, adults and pregnant women. The lozenge is not classified as a drug and is regulated as a nutritional supplement. The lozenge does contain the sugar substitutes called mannitol and sorbitol (sugar alcohols), as well as the natural sweetener, stevia, all of which can irritate the lower gastrointestinal tract at amounts that grossly exceed the levels that are contained in the lozenges (I lozenge contains \<l % of the recommended daily intake).
  • Water additive (Tradename Protektin) — DIETARY_SUPPLEMENT
    Commercially marketed over-the-counter Protektin drinking water additive contains ingredients that are all FDA-approved with the GRAS designation, and have years of safety demonstrated in animals, children, adults and pregnant women. The water additive is not classified as a drug and is regulated as a nutritional supplement. The water additive only contains active ingredients; it does not contain fillers, flavors or sweeteners.

Study Details

The goals of this clinical study are: 1. Survey approximately 600 persons between the ages of 18-80 regarding their medical history \& oral hygiene habits, diet \& exercise habits, and emotional \& physical stressors to understand the barriers this population may face in achieving or maintaining good oral care and whole body health. 2. Compare the survey results with the organic molecule data collected by oral swabs from each subject at three different time points over the course of their 60 day study participation to better understand how behaviors and medical history relate to oral and whole body health. 3. Assess the effectiveness of two marketed oral hygiene study products vs a control on oral microbiome--such as bacteria, fungi, viruses that live naturally in our body-as well as its impact on the oral microbiome of each subject. The study products used in this study are 1 marketed oral lozenge, 1 marketed water additive.

Key Dates

Start date
Apr 30, 2024
Status verified
Feb 2026
Primary completion
Jul 11, 2024
Completion
Jul 23, 2025

Study Design

Enrollment
595 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Active Comparator: Lozenge Intervention (Tradename pHossident)
    This cohort was randomized and assigned into the pHossident Lozenge cohort. They received 8 lozenges per day for the duration of the study. They completes questionnaires. They were sampled orally at Baseline, Week 4 and Week 8 for multi-omic analyses.
  • No Intervention: Control
    Full participation but received no intervention
  • Active Comparator: Water Additive Intervention (Tradename Protektin)
    This cohort was randomized and assigned into the Protektin water additive cohort. They received 2 water additive sachets per day for the duration of the study. They completes questionnaires. They were sampled orally at Baseline, Week 4 and Week 8 for multi-omic analyses.

Primary Outcome Measure

Metagenomic changes at 4 and 8 weeks from baseline in pHossident lozenge recipients vs Protektin water additive recipients vs control participants using shotgun sequencing of salivary DNA isolates sequencing depth of 35.4M read pairs per sample. [ Time Frame: Initial visit: baseline measurements to 8 week endpoint measurements ]

Locations (1)

FacilityCityStateZIPSite coordinators
Comprehensive Research GroupMinneapolisMinnesota55415-

Find similar trials in Minneapolis, MN

Related Studies